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Wilms’ tumors (WTs) originate from metanephric blastema cells that are unable to complete differentiation, resulting in triphasic
tumorscomposedofepithelial,stromalandblastemalcells,withthelatterharboringmolecularcharacteristicssimilartothoseof
the earliest kidney development stages. Precise regulation of Wnt and related signaling pathways has been shown to be crucial
for correct kidney differentiation. In this study, the gene expression proﬁle of Wnt and related pathways was assessed in laser-
microdissected blastemal cells in WTs and differentiated kidneys, in human and in four temporal kidney differentiation stages
(i.e. E15.5, E17.5, P1.5 and P7.5) in mice, using an orthologous cDNA microarray platform. A signaling pathway-based gene
signature was shared between cells of WT and of earliest kidney differentiation stages, revealing genes involved in the
interruption of blastemal cell differentiation in WT. Reverse transcription-quantitative PCR showed high robustness of the
microarray data demonstrating 75 and 56% agreement in the initial and independent sample sets, respectively. The protein
expression of CRABP2, IGF2, GRK7, TESK1, HDGF, WNT5B, FZD2 and TIMP3 was characterized in WTs and in a panel of human
fetal kidneys displaying remarkable aspects of differentiation, which was recapitulated in the tumor. Taken together, this study
reveals new genes candidate for triggering WT onset and for therapeutic treatment targets.
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Conserved mechanisms that underlie the relationship
between normal development and tumorigenesis may give
insights into the earliest events that drive transformation.
Normal kidney differentiation requires a ﬁne regulation of
morphogenetic events, and its deregulation may lead to
kidney abnormalities, including agenesis, dysplasia, hypopla-
sia and tumors.
1 Wilms’ tumor (WT), or nephroblastoma,
arises from metanephric blastemal cells that are unable to
complete the mesenchymal–epithelial transition (MET) result-
ing in a tumor with varying proportions of undifferentiated
blastemal and stromal cells and primitive epithelial structures.
These histological features resemble fetal kidneys (FKs) and
make WT a model for morphological recapitulation of the
earliest kidney developmental stages.
1,2
Additional evidence for recapitulation of the earliest kidney
differentiation stages in WT has been provided by molecular
studies, exempliﬁed by the WT1, IGF2 and other genes,
implicated in nephrogenesis and associated with Wilms’
tumorigenesis.
2,3 A high degree of similarity has also been
detected in gene expression proﬁles of the earliest kidney
differentiation stages and whole WT.
4,5 More recently, we
have providedevidence that, amongthe three histological WT
components,blastemalcellsdisplayageneexpressionproﬁle
similar to that found in the initial stages of nephrogenesis,
suggesting that the blastemal component, and not the whole
tumor, preserves the molecular events involved in WT onset.
6
Kidney differentiation involves complex interactions
between epithelial and mesenchymal cells, and signal
transduction pathways have a fundamental role in controlling
cell–cell interactions. The Wnt signaling pathway, an inter-
related pathway with key roles in embryogenesis and cancer,
consists of two highly connected main branches, namely the
CTNNB1-dependent and the CTNNB1-independent Wnt
pathways. The CTNNB1-dependent pathway is essential for
controlling embryonic development and adult cell home-
ostasis. b-Catenin, encoded by CTNNB1, functions as
coactivator of the TCF/LEF family of transcription factors during
embryonic development and is a key component of cell–cell
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www.nature.com/cddisadhesion complexes in differentiated cells. Wnt ligands activate
the CTNNB1-dependent pathway, leading to nuclear accumu-
lation of b-catenin, which acts as a coactivator for transcription
factors. In the absence of Wnt ligands, this pathway is
inactivated by a destruction complex that phosphorylates
b-catenin, leading to ubiquitination, proteasomal degradation
and prevention of b-catenin accumulation in the nucleus.
7
Therefore, nuclear accumulation of b-catenin is an indirect
marker for pathway activation and has been observed in
WT.
8–10 APC, a component of the b-catenin destruction
complex, is also found in the nucleus of blastemal cells in the
earliest embryonic kidney stages and in WT.
6 The CTNNB1-
independent Wnt pathway comprises two segments, namely
theplanarcellpolarityandcalciumsignalingsegments,
11andits
proper regulation has also been considered important in
maintainingcorrectcelldifferentiationinthekidney.Thecalcium
signaling components PLCG2
6 and WNT5A
12 are down-
regulated in WT, and their ﬁne regulation seems to have an
important role in kidney differentiation.
The strong connection between nephrogenesis and WT
highlights the importance of characterizing gene expression
modulation in the Wnt and related signaling pathways.
Identiﬁcation of genes expressed during kidney differentiation
arrest may be necessary to determine the earliest alterations
that drive WT onset and, consequently, are potential
molecular markers or therapeutic target candidates. In this
study, we characterized gene expression patterns of the Wnt
and related signaling pathways in blastemal cells in kidney
developmental stages in mice and in WT in humans. For this
purpose, we established a cross-species hybridization model
to assess the gene expression modulation in both species on
a cDNA platform. Our ﬁndings revealed 18 genes commonly
regulated in the earliest kidney developmental stages and in
WT. Expression patterns based on this gene set could
discriminate blastemal WT cells and FK cells from those of
differentiated kidneys (DKs) from both species. Detailed
characterization of the protein expression of human FKs and
WT revealed some interesting aspects of gene modulation in
nephrogenesis and in WT. Overall, we revealed new genes
that determine kidney differentiation arrest and are potential
molecular markers or therapeutic target for WT patients.
Results
Evaluation of cross-species hybridization for the
construction of a cDNA platform. To test the robustness
of interspeciﬁc hybridizations, we interrogated 1334
sequences classiﬁed as highly conserved regions of human
and mouse orthologous using RNA from kidney and liver of
both species (see Material and Methods). Correlation
between technical replicates and variance among the
triplicate hybridization experiments were compared
between interspeciﬁc (mouse RNA samples and human
cDNA platform) and intraspeciﬁc (human RNA samples and
human cDNA platform) hybridizations, with the latter
considered the gold-standard experiment.
Technical replicates of interspeciﬁc hybridizations gener-
ated highly reproducible data, with Pearson’s correlations
ranging from 83 to 86% (average¼84.7%), similarly to
intraspeciﬁc hybridizations, which resulted in 88–95%
(average¼91.3%). To evaluate variance across the experi-
ments, Levene’s test was used to compare the ﬂuorescence
intensities of each spot in the intraspeciﬁc and interspeciﬁc
hybridization replicates. For 90.6% of the spots (1195 out of
1334), the variability across the interspeciﬁc hybridizations
was equal to or lower than that across the intraspeciﬁc
hybridizations.
These analyses indicated that the criteria for deﬁning highly
similar orthologous sequences and the hybridization condi-
tions resulted in robust interspeciﬁc hybridization data that
were similar to data obtained for the intraspeciﬁc hybridiza-
tions.
Therefore, the same criteria for deﬁning similar regions in
the cDNA sequences (i.e. an e-value
 5 and a minimum
alignment of 50%) were used for constructing the orthologous
cDNA platform used in this study. In total, 326 orthologous
cDNA partial fragments with high similarity at the nucleotide
level between human and mouse (HM) sequences were
immobilized on a custom cDNA platform (Supple-
mentary File 1) to assess gene expression regulation in both
species.
Characterization of differentially expressed genes
between WT and DK. From the 326 Wnt and related
signaling pathway genes assessed in WT and DK, 47 were
differentially expressed; and 18 and 29 were downregulated
and upregulated in WT, respectively (Po0.05; Table 1).
Annotation of the biological processes classiﬁed the 47
differentially expressed genes into cell communication,
development, organogenesis, morphogenesis, phosphoryla-
tion, regulation of transcription, transport and other categories
without any detectable preferential distribution (Table 2).
Identiﬁcation of genes involved in the earliest event that
drives WT onset. To identify genes that recapitulate the
expression proﬁle of the earliest kidney developmental
Table 1 Differentially expressed genes between WT and DK
Downregulated genes in WT Upregulated genes in WT
CDC7 ITPR3 VANGL2 COL5A1 CARKL DMPK PIK3C3
CDH6 MAPK9 WNT3 INPP5B WNT5B CRABP2 HDGF
CDS1 OCRL WNT5B EYA3 SFRP2 FRZB PPP2R1A
DVL2 PIK3CA LRP6 FZD2 GRK7 JUN
EYA4 PIK3CD PIP5K2B IGF1R TESK1 IGF2
FN3K PIP5K2C PAX2 LRP1 TCF7L2
FRAT2 TBL1XR1 PCTK2 FZD4 OFD1
HIPK1 TIMP3 FZD10 CSNK2A1 RGS4
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Cell Death and Diseasestages and consequently drive tumorigenesis in WT, genes
downregulated and upregulated in WT, compared with DK,
were compared with genes with increasing and decreasing
behavior during kidney cell differentiation. The 326 genes
were evaluated in 4 stages of mouse nephrogenesis, which
represent the differentiation of metanephric blastema into
fully DK cells, revealing 72 and 64 genes with increasing
and decreasing expressions, respectively (Supplementary
Figure 1). The others 190 genes presented diverse
expression behavior during kidney cell differentiation and
were not further analyzed.
Thus, the 72 increasing genes were compared with the 18
WT blastemal cell downregulated genes, and the 64
decreasing genes were compared with the 29 WT blastemal
cell upregulated genes. This analysis revealed that 18 genes,
7 with increasing and 11 with decreasing expressions during
mouse metanephric blastema cell differentiation (Figure 1a),
were downregulated (TIMP3, HIPK1, CDH6, ITPR3, FRAT2,
PIK3CA and MAPK9) and upregulated (PAX2, FZD10,
CARKL, WNT5B, FZD2, CRABP2, FRZB, GRK7, TESK1,
HDGF and IGF2) in WT blastemal compared with DK cells,
respectively.
Hierarchical clustering based on the expression pattern of
the 18 genes grouped differentiated and intermediate kidneys
from humans and mice together and discriminated them from
WT samples, which were grouped with the pool of human FKs
and the earliest mouse embryonic kidneys (Figure 1b). This
result revealed two important aspects of this study: the model
for interspeciﬁc hybridization was appropriate for studying
humantumorigenesisandmouseembryogenesis,andagene
expression signature linked to Wnt and related signaling
pathways was associated with WT onset.
A high level of robustness was detected in this study, with
75% agreement between microarray and reverse transcrip-
tion-quantitative PCR (RT-qPCR) experiments in the initial
sample set. In total, 9 out of 12 genes displayed concordant
expression. CRABP2, HDGF, IGF2, PAX2, SHPK, TESK1
and WNT5B were upregulated and HIPK1 and TIMP3 were
downregulated, in WT blastemal cells compared to DK
glomerular cells (Figure 1c). Interestingly, hierarchical clus-
tering based on the 12 genes assessed by RT-qPCR,
independent of their validation, could discriminate DK from
100% of WT samples (Supplementary Figure 3) reinforcing
the association of this gene signature with WT.
Evaluation of expression levels using a broader group of
WT and DK samples. To assess the transcriptional
difference of the 9 technically validated genes (CRABP2,
IGF2, PAX2, WNT5B, TIMP3, HIPK1, TESK1, SHPK and
HDGF) in samples with different biological backgrounds, we
evaluated an independent group of 35 blastema-enriched
WT and 13 cortex-enriched DK samples. The data from
CRABP2, HDGF, IGF2, TIMP3 and WNT5B agreed with the
initial sample group. HIPK1 did not satisfy the fold-change
criteria (Z3), despite showing statistical signiﬁcance
(Figure 2).
Characterization of protein expression in WT and during
human kidney embryogenesis. First, correspondence
between the mRNA and protein was evaluated based on
the immunohistochemical labeling intensity of each protein in
the blastemal WT and glomerular DK cells. Proteins encoded
by 8 out of 18 genes were evaluated in 145 WT and 20 DKs.
A high percentage of agreement was observed, with 5 out of
8 (62.5%) genes displaying the same expression tendency at
mRNA and protein levels. CRABP2, GRK7, HDGF, IGF2 and
TESK1 were overexpressed in WT. WNT5B and FZD2 did
not show a difference between WT and DK, and TIMP3 had
opposite results, that is, its mRNA was underexpressed in
WT, and its protein product was overexpressed (Figure 3).
Second, protein positivity was characterized in embryonic
kidneys, from undifferentiated mesenchymal metanephric to
fully differentiated cells. Inaddition, WT and DK samples were
classiﬁed as either negative or positive for each protein
(Table 3).
A protein expression proﬁle that recapitulated the earliest
kidney developmental stages could be observed in WT for the
majority of the eight assessed proteins (Figure 3).
Cytoplasmic and some nuclear CRABP2 positivity was
detected in every cells undergoing MET after ureteric bud
induction and before cells adopted an epithelial morphology.
CRABP2 was not detected at any of the subsequent cell
differentiation stages. The majority of WT samples displayed
strong CRABP2 expression in the nucleus (107 out of 113
samples) and in the cytoplasm (101 out of 108 samples).
With regard to IGF2, cytoplasmic positivity was observed in
all embryonic kidneys, with a slightly stronger positivity in the
earliest stages. DK cells were considered IGF2 negative, and
in WTs, IGF2 expression was observed in 96 out of 112
blastemal cells.
GRK7 was observed in the cytoplasm and in membranes of
all embryonic kidneys, showing a slight decrease in the DK. In
DK cells, half of the glomerular cells reported positive
cytoplasm labeling, and the majority of cells also presented
membrane positivity. All but one blastemal WT sample were
positive for GRK7 in the cytoplasm (105 out of 106 samples)
and in the membrane (116 out of 117 samples).
Table 2 Classiﬁcation of differentially expressed genes between relapse and no-relapse WT samples within the biological process categories
Biological process categories Upregulated genes in WT Downregulated genes in WT
Cell communication INPP5B, PIP5K2B, RGS4 CDH6, CDS1, DVL2, FRAT2, PIK3CA,
WNT3, WNT5B
Development, organogeneis,
morphogenesis
EYA3, FRZB, FZD10, FZD2, FZD4, GRK7, IGF2,
PAX2, PPP2R1A, SFRP2, WNT5B
EYA4, VANGL2
Phosphorylation CSNK2A1, DMPK, IGF1R, PCTK2, PPP2R1A, TESK1 HIPK1, MAPK9, PIP5K2C, PIK3CD
Regulation of transcription COL5A1, HDGF, JUN, TCF7L2 —
Transport CRABP2, LRP1, PIK3C3 ITPR3
Others CARKL, LRP6, OFD1 CDC7, FN3K, OCRL, TBL1XR1, TIMP3
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Cell Death and DiseaseFigure1 Wilmstumorsignatureset.(a)Expressionbehaviorofthe18genesduringnephrogenesisinmouse.kandmindicatedownregulationandupregulationinWilms
tumor, respectively, in comparison with differentiated kidney at transcriptional level. (b) Unsupervised hierarchical clustering based on expression pattern of the 18 genes.
Black lines correspond to 90–100% of reliability assessed by Bootstrap. (c) Comparison of cDNA microarray and RT-qPCR experiments. (*) Represents differentially
expressedgenesassessedbyRT-qPCRthatfulﬁlledcutoffcriteria(foldchange43andPo0.05).(d)Legendofcolors.FK,fetalkidney;WT,Wilmstumor;DK,differentiated
kidney; P1.5, 1.5-day-old mouse kidney; E17.5 and E15.5, fetal kidney from 17.5 and 15.5-day-old mouse embryo, respectively
WTand kidney development
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Cell Death and DiseaseTESK1 exhibited a weak cytoplasmic positivity, primarily
in tubular cells and a few embryonic kidney glomerular
cells; in DKs, some glomerular cells were also positive.
TESK1 showed positive staining in the cytoplasm of the
majority of the WT blastemal components (110 out of 114
samples).
HDGFnuclearpositivitywasobservedinsomecellsfromall
FK stages and DK. HDGF was positive in the cytoplasm of 56
out of 118 cells and in the nucleus of 52 out of 111 WT
blastemal components.
TIMP3 was labeled in cell membranes and in the nuclei of
embryonic kidney cells. TIMP3 was also observed in the
cytoplasm and nucleus of DKs and in WT blastemal cells;
however, stronger labeling was observed in the latter.
Whereas the majority of samples were positive in the
cytoplasm (101 out of 116 samples) less than half were
positive in the nucleus (47 out of 111 samples).
In nephrogenesis, WNT5B was observed after renal vesicle
formation,whencellsareorganizingtoformkidneystructures,
such as glomeruli and tubules. WNT5B positivity was
observed mainly in the apical cell membrane. In DK, WNT5B
nuclear positivity was observed in some cells. In the WT
blastemal component, WNT5B was observed in the cyto-
plasm in 8 out of 120 samples and in the membrane in 28 out
of 113 samples.
With regard to FZD2, FKs were membrane positive in cell
types ranging from undifferentiated metanephric blastema
cells to differentiated glomerular and tubular cells. In WT
blastemal cells, FZD2 was observed in the membrane in 37
out of 106 samples.
Figure 2 Biological evaluation of differentially expressed genes. Comparison of gene expression between Wilms tumor and differentiated kidney. WT: Wilms tumor; DK:
differentiated kidney; F: fold change and P: P-value axis Y: Log2 relative expression. Negative and positive values correspond to downregulation and upregulation in WT,
respectively. (*) Represents differentially expressed genes with fold change 43 and Po0.05
WTand kidney development
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Cell Death and DiseaseAssessment in relapse and no-relapse WT samples. To
determine whether the 9 technically validated genes (i.e.
CRABP2, IGF2, PAX2, WNT5B, TIMP3, HIPK1, TESK1,
SHPK and HDGF) had a role in the latter events of WT
progression, their expression levels were assessed in 35
blastemal-enriched WT samples that included 12 relapse
and 23 no-relapse samples (Supplementary Figure 4). Only
IGF2 was differentially expressed (Po0.01); presenting
downregulation in relapse WTs. TESK1 was also
downregulated in relapse WTs, but the P-value was
borderline (P¼0.06).
In addition, in an effort to ﬁnd prognostic markers for WT,
possible associations between protein expression (CRABP2,
GRK7, HDGF, IGF2, TESK1, WNT5B, FZD2 and TIMP3) and
clinicopathological variables (relapse, clinical stage, ﬁrst
treatment, number of drugs used, death, age of diagnosis
and gender) were evaluated. No association was found,
reinforcing that these molecular events had a role rather in
tumorigenesis than in progression of WT.
Discussion
Embryonic tumors are intimately linked to embryogenesis,
tissue growth and maturation process. Embryogenesis and
tumorigenesis have been shown to share regulatory mechan-
isms in several tumors including WT.
4–6 Approaches that
enabletheassessmentofbothprocesseshavebeenroutinely
used to uncover key molecular events that lead to cell
transformation.
Nephrogenesis is a continuous process that involves
different cell types, in variable proportions, the spatiotemporal
localization of which has a role in the correct differentiation of
the functional kidney. The triphasic WT histology resembles
FK cells.
13 We previously analyzed the gene expression
patternofblastemal,stromalandepithelialcomponentsofWT
separately and showed that blastema displays the most
similar gene expression pattern of the initial stages of
nephrogenesis, and that the Wnt signaling pathway is
supposedly involved in the earliest events of WT onset.
6
In the current study, a cell-resolution expression analysis
was used for identifying disturbances in gene modulation of
blastemal cell differentiation that can trigger a permissive
conditionfortumordevelopment.Weanalyzedtheexpression
modulation of Wnt and related signaling pathways genes in
primordial blastemal WT cells and in four FK stages to identify
conserved mechanisms in the earliest stages of kidney
embryogenesis that recapitulate Wilms’ tumorigenesis. The
rationale behind this experimental design was to deﬁne
alterations in gene expression modulation that are involved
in the disruption of the differentiation process in the kidneys
that lead to WT onset. To monitor gene expression in both
processes, that is, tumorigenesis in humans and embryogen-
esis in mice, we used stringent parameters and generated
reliable data from cross-species hybridization.
The signature of 18 Wnt and related signaling pathways
genes displayed an expression pattern that was modulated
during the differentiation of blastemal cells in nephrogenesis.
Additionally the expression pattern of blastemal cells from the
earliest stages of nefrogenesis in mice was recapitulated in
blastemal cells from the WT in human. These results reinforced
the importance of these genes in WT onset and also validated
the approach used in this study.
Activation of the canonical Wnt signaling pathway has been
continuously detected in WT veriﬁed by nuclear positivity of
APC
6 and b-catenin.
8–10,14 In spite of the fact that no
experimental evidence has been provided in this study to
connect the 18 genes and activation of the canonical Wnt
pathway,itisreasonabletosuggesttheirinvolvementwiththis
process in both nephrogenesis and WT.
Among the nine technically validated genes, PAX2, IGF2,
CRABP2, HDGF, SHPK, TESK1 and WNT5B were upregu-
lated and HIPK1 and TIMP3 were downregulated at the
mRNA level in WT blastemal cells than in DK glomerular cells.
PAX2 (located at 10q24) is a transcription factor that is
expressed in FK nephrogenic structures and in WT, but is
absent from the DK.
15 PAX2 expression is suppressed by
WT1, and both are essential for kidney development.
16
Inactivating WT1 mutations have been observed in B10%
of sporadic WT cases,
17 and germline mutations are
associated with syndromes that include an increased WT
incidence.
13 Consistent with these data, PAX2 was similarly
upregulated in this study at the mRNA level in WT as
compared with the earliest FK developmental stages.
IGF2 (located at 11p15.5) is an embryonic growth factor
and a member of the insulin family of polypeptides, with a role
in kidney embryogenesis.
18 Under physiological conditions,
the IGF2 maternal allele is silenced by genomic imprinting,
and the gene is expressed only by the paternal allele;
however, WT exhibits a markedly increased expression
relative to DK.
19,20 As expected, IGF2 upregulation was
detected in the earliest nephrogenesis stage, and this was
recapitulated by WT both at the mRNA and at the protein
levels.
WNT5B (located at 12p13.3) encodes a secreted Wnt
signaling protein. CGH arrays of WTs have revealed a high
level of gain of the WNT5B chromosomal locus,
21 which is in
accordance with the transcriptional upregulation found in our
study. However, no alteration at the protein level was
observed in our results.
In addition, ampliﬁcation of the chromosome region 1q22-
q23.1, where HDGF and CRABP2 are located, was also
observed in WT samples,
21 and this is in agreement with the
Figure 3 Representative sections of immunohistochemical staining in Wilms tumor, fetal and differentiated kidneys. Proteins are identiﬁed in each block. Antibody
speciﬁcity was determined by western blot (panels above graphics). Cell line and molecular weight are indicated. HEK293: human embryonic kidney cell line, SK-NEP-1:
Wilmstumorcellline. Graphics:Y axis—proteinquantiﬁcationbased on proteinintensityvalues.X axis:Wilmstumor (right)and differentiated kidney(left)samples.A, D,G, J,
M, P, S and V: representative samples of Wilms tumor. B, E, H, K, N, Q, T and X: representative samples of fetal kidneys. Fetal kidneys from thirteenth week human embryo:
HDGF, IGF2, GRK7, WNT5B and TIMP3; fetal kidneys from seventeenth week human embryo: CRABP2 and FZD2, and; fetal kidneys from the twenty-fourth week human
embryo:TESK1.C, F, I,L, O, R,U, Y representativesamplesof differentiatedkidney,onlycells fromglomerulous wereanalyzed.WT: Wilmstumor; DK:differentiatedkidney.
(*) Represents differentially expressed genes with Po0.05. Black bars represent 100.1 or 100.3mm as indicated in the green box
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Cell Death and DiseaseFigure 3 Continued
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Cell Death and Diseaseoverexpression observed in our study. Our data also
demonstrate slight HDGF overexpression at the protein level
inblastemalcellsthaninDKglomerularcells,whichreinforces
the idea that HDFG is downregulated throughout organ
differentiation.
In this study, CRABP2 was upregulated both at the mRNA
andat the protein level in WT blastemal cells than in cells from
the cortex of DK samples in accordance with other studies in
WT.
22,23 However, CRABP2 downregulation has been
observed in others tumor types including head and neck
squamous cell carcinoma, in which a highly frequent
hypermethylation rate was detected.
24 CRABP2 encodes a
cytosolic member of the retinoic acid-binding protein family
involved in vitamin A metabolism, and moves to the nucleus
upon binding of retinoic acid.
25 This cytosol-to-nuclear
shuttling protein has an important role in embryogenesis.
CRABP2 positivity was observed in a speciﬁc moment of
kidney development when cells were going through MET after
ureteric bud induction. This expression proﬁle during nephro-
genesisandthenuclearandcytoplasmaticpositivityobserved
inthemajorityofWTblastemalcomponentsstronglysuggests
that CRABP2 mediates MET signaling of metanephric
mesenchymal cells in the FK. Retinoic acid has been
suggested for treatment of WT,
5,22,23 which indicates the
necessity to carefully study CRABP2 and retinoic acid in the
context of WT and nephrogenesis. Little is known about the
functional roles of retinoic acid and CRABP2 in kidney
differentiation and WT tumorigenesis.
TIMP3 (located at 22q12.13) is a member of the TIMP gene
family, which includes inhibitors of the matrix metalloprotei-
nases and peptidases involved in degradation of the extra-
cellular matrix. TIMP3 is also an angiogenesis inhibitor that
inhibits VEGF binding to VEGFR2.
26 We found decreased
expressionatthemRNAlevelandincreasedexpressionatthe
protein level in WT, suggesting a posttranscriptional mechan-
ism of protein regulation for TIMP3.
GRK7 (located at 3q24) encodes a member of the guanine
nucleotide-binding protein (G protein)-coupled receptor
kinase subfamily of the serine threonine protein kinase family.
FZD2 (located at 17q21.1) encodes a seven-transmembrane
domain protein involved in the signaling of both CTNNB1-
dependent and CTNNB1-independent Wnt pathways. FZD2
has been shown to be overexpressed in FKs and stem-like
WTxenografts.
2Accordingly,weobservedupregulationatthe
mRNA level in WT and in the earliest kidney stages.
In addition, WNT5B and FZD2 belong to the Wnt calcium
signaling pathway, which has been recently shown to be
involved with nephron formation through Wnt4 in mouse.
27
Interestingly, blastemal cells that express WNT5B also
express FZD2 in FKs, although not all cells that express
FZD2 express WNT5B (data not shown). Furthermore,
glomerular DK cells and the epithelial component (the most
differentiated WT component) express both proteins (data not
shown), which supports the involvement of Wnt calcium
signaling in blastemal cell differentiation, which may be
perturbed in WT.
In spiteof the fact thatexperimental delineation hasfavored
identiﬁcation of genes involved in the earliest event of WT
onset that not necessarily have a role in WT progression, two
genes, namely IGF2 and TESK1, presented mRNA down-
regulation (with marginal statistical signiﬁcance), showing a
slightly association with relapse, which has been constantly
investigated for better stratifying WT patients.
21,23,28,29
Further studies are necessary to deﬁnitively estimate the
value of these genes for prognostic marker to be introduced in
WT clinical routine.
Table 3 Characterization of proteins expression in blastemal cells of WT, glomerulous cells of DK and in different stages of fetal kidneys
WT DK
Protein Localization Negative Positive Negative Positive Nephrogenesis
CRABP2 Cytoplasm 6 (5.31%) 107 (94.69%) 18 (100%) 0 (0%) Cytoplasm expression in cells going through MET
Nucleus 7 (6.48%) 101 (93.52%) 17 (100%) 0 (0%)
HDGF Cytoplasm 62 (52.54%) 56 (47.56%) 12 (100%) 0 (0%) Nuclear and cytoplasm expression in all stages of
kidney differentiation
Nucleus 59 (53.15%) 52 (46.85%) 18 (90%) 2 (10%)
GRK7 Cytoplasm 1 (0.94%) 105 (99.06%) 11 (55%) 9 (45%) Decreasing cytoplasm expression in cells during
kidney differentiation
Membrane 1 (0.86%) 116 (99.16%) 2 (9.09%) 20 (90.91%)
TIMP3 Cytoplasm 15 (12.90%) 101 (87.10%) 26 (83.87%) 5 (16.13%) Decreasing cytoplasmatic expression in blastemal
cells during kidney differentiation
Membrane 64 (57.66%) 47 (42.34%) 21 (100%) 0 (0%)
WNT5B Cytoplasm 112 (93.33%) 8 (6.67%) 10 (100%) 0 (0%) Protein observed in the apical membrane of lumen
cells that originate kidney structures
Membrane 85 (75.22%) 28 (24.78%) 12 (60%) 8 (40%)
FZD2 Membrane 69 (65.10%) 37 (34.90%) 3 (18.75%) 13 (81.25%) Membrane expression in all stages of kidney cell
differentiation
TESK1 Cytoplasm 4 (3.51%) 110 (96.49%) 20 (100%) 0 (0%) Decreasing cytoplasm expression in cells during
kidney differentiation
IGF2 Cytoplasm 16 (14.29%) 96 (85.71%) 10 (100%) 0 (0%) Decreasing cytoplasmatic expression in cells during
kidney differentiation
Abbreviation: MET, mesenchymal–epithelial transition
WTand kidney development
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Cell Death and DiseaseIt is possible that the utility of these gene expression data, in the
context of molecular markers, will be in the application of
therapeutic WT intervention because expression changes of these
18 genes seem to be in the earliest events in cell transformation. In
addition, these alterations are present in the majority of tumor cells
that increase their importance as molecular markers.
In summary, this study provides a clearer outline of the
disruption of nephrogenesis and reveals new Wnt and related
signaling pathway genes, which are highly likely to have
crucial roles in WT biology.
Materials and Methods
Establishment of criteria for highly similar cDNA regions of
orthologous genes. To identify highly similar regions between HM
orthologous genes, 4608 partial human cDNA sequences immobilized on a
custom cDNA platform
30 were BLASTed against mouse transcriptome databases
(i.e. MGC, RefSeq and mRNAs/HTCs) using an e-value of  5 and a minimum
alignment of 50% as parameters. This analysis revealed 1334 human sequences
with matched mouse orthologous sequences. Visual inspection revealed an
average similarity of 87%, which ranged from 79 to 98%, between sequences.
These sequences were classiﬁed as highly conserved regions of HM orthologs
(hcrHMs).
Reproducibilitytest of HM interspecies microarray hybridization.
. To determine the ideal hybridization conditions for HM interspecies hybridization, frozen
humansamples stored at  1401Cfromthreenormal kidneysandthreenormal livers were
obtained from the A.C. Camargo Hospital Tumor Tissue Biobank (Sa ˜o Paulo, Brazil), and
total RNA pools were generated. A kidney and a liver were removed from an adult CD1
mouse, andtotalRNAwas isolatedusingTRIzol(InvitrogenLifeTechnology, Carlsbad, CA,
USA), according to the manufacturer’s protocol.
A two-round RNA ampliﬁcation was performed for all HM samples.
6 Labeled
cDNA was generated by reverse transcription using 7mg of ampliﬁed RNA (aRNA),
random hexamer primers (Invitrogen), Cy3- or Cy5-labeled dCTP (Amersham
Biosciences, Piscataway, NJ, USA) and SuperScript II (Invitrogen) according to the
manufacturer’s protocol. Dye-swap experiments were performed for intraspeciﬁc
(i.e. human samples and a human cDNA platform) and interspeciﬁc (i.e. mouse
samples and a human cDNA platform) hybridizations for dye bias control.
Prehybridization and hybridization were performed as described previously.
6 After
background subtraction, quantiﬁed signals were log transformed, and a nonlinear
normalization (Lowess) was applied to correct experimental bias within each array.
Dye-swap hybridizations were performed in triplicate for HM samples, and
generated data were used for mathematical and statistical analyses. The
reproducibility of signal intensities was evaluatedfor the 1334 hcrHMs by Pearson’s
correlations between replicates and Levene’s tests among triplicates.
31 For the
latter, spot signal intensity values from HM triplicates were plotted to calculate the
S.D. and signal intensity variance. Variance values from the intraspeciﬁc
hybridizations were used as a standard and compared with those from the
interspeciﬁc hybridizations.
Construction of a cDNA platform for HM interspecies microarray
hybridization. To deﬁne the hcrHMs of 326 genes representative of Wnt and
related signaling pathways(SupplementaryFile 1), humanFASTA sequences were
BLASTed against mouse transcriptome databases (i.e. MGC, RefSeq and
mRNAsHTCs) using described parameters (450% identity and an e-value of  5).
Primers were designed to ﬂank the hcrHMs of 101 genes, and RT-PCR was
performedusingcDNAsconvertedfromapooloftotalRNAfrom15humancelllines
as described previously.
32 The amplicons were extracted from 1% agarose gel and
cloned using the InsTAclone kit (Fermentas Life Science , Hanover, MD, USA). For
225 genes, a cDNA clone that covered at least 80% of the respective hcrHMs was
retrieved from our cDNA bank from the Human Cancer Genome Project.
33,34 All
cDNAs were ampliﬁed using universal reverse or forward primers, sequenced in a
3130xl Capillary Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) to
conﬁrm cDNAs’ identities, puriﬁed with G50 resin and arrayed onto glass slides
using a Flexys robot (Genomic Solutions, Ann Arbor, MI, USA).
The cDNA platform comprised 2352 spots and included 326 hcrHMs, 1384
additional human cDNA sequences, 496 negative controls (DMSO) and 48 positive
controls (the Q gene from l-phage).
Tissue sample and cell laser microdissection. In total, 59 frozen
samples with favorable WT histology, including a predominance of blastemal
component histology, were received from COG (Children’s Oncology Group).
Sections of 5mm from fresh frozen tumor blocks were excised onto glass slides and
stained with hematoxylin and eosin for review by a pathologist (FAS).
ThePixCellIILCMsystem(ArcturusEngineering,MountainView,CA,USA)was
used for laser microdissection of 24 blastemal cells. Samples were mounted onto
glass slides and stained with 100ml of nuclear fast red (Certistain; Merck) for
visualization using CapSure Macro LCM Caps (Arcturus Engineering). These
samples were used for cDNA microarrays and technical validation experiments. For
an independent sample group, 35 out of the 59 samples were scalpel dissected to
enrich for blastemal cells (a minimum of 80%) for the RT-qPCR validation steps. In
all, 17 histologically normal DKs were retrieved from A.C. Camargo Hospital Tumor
TissueBiobank.Glomerularcellsfrom4outof17kidneyswerelasermicrodissected
andusedforthecDNAmicroarrayexperiments.Therenalcorticesfrom13 outof17
kidneys were dissected for the RT-qPCR validation steps. On average, 2000 cells
were captured for laser-microdissected samples (Supplementary Figure 2).
The kidneys from CD1 strain mice were isolated from embryos (E) and postnatal
animals (P) at ages E15.5, E17.5, P1.5 and P7.5. Three animals from each age
were independently processed and used as replicates, except for E15.5, which was
represented by one embryo. Dissected tissues were immediately frozen in liquid
nitrogen and treated as described above. Cells from metanephric mesenchyme,
metanephric blastema and fully differentiated glomerulus were laser microdis-
sected, considering the proportions of each cell type in each mouse stage, using
CapSure HS LCM Caps (Arcturus Engineering). On average, 400 cells were
captured.
Two pathologists(FAS and RC) supervised all dissection procedures.This study
was in accordance with the principles of the Declaration of Helsinki and was
approvedby the A.C. Camargo Hospital Ethics Committeeunder number CEP 764/
06 for human samples. All animal experiments were also conducted according to
the guidelines of the A.C. Camargo Hospital Animal Ethics Committee under the
number CEUA 006/06.
RNA extraction and ampliﬁcation. RNA from laser-microdissected
samples was puriﬁed using the PicoPure RNA isolation kit (Arcturus Engineering)
and treated using an RNase-Free DNase set (Qiagen, Germantown, MD, USA).
Total RNA from scalpel-dissected samples was extracted using TRIzol (Invitrogen).
To generate aRNA, we used the RiboAmp RNA ampliﬁcation kit, and the RiboAmp
HS plus kit (Arcturus Engineering) for HM samples, respectively. RNA quantity and
purity were determined by spectrophotometry NanoDrop ND-1000 (Thermo
Scientiﬁc, Wilmington, DE, USA). Total RNA integrity was analyzed by Agilent
Bioanalyzer2100(AgilentTechnologies,PaloAlto,CA,USA)andonlythosewithan
OD 260/280Z1.8 and an RIN45.0 were used for microarray and RT-qPCR
experiments.
cDNA microarray experiments. A pool of RNAs
32 was used as the
referencesample.LabeledcDNAwasgeneratedusing7and4mgofaRNAfromthe
test and reference samples, respectively, random hexamer primers (Invitrogen),
Cy3-orCy5-labeleddCTP(AmershamBiosciences)andSuperScriptIII(Invitrogen)
forcompetitivehybridizationtothecDNAplatform.Dyeswappingwasperformedfor
each sample to control for dye bias, and this was used as a replicate.
For mouse samples, dye-swapping experiments were conducted in triplicate for
animals aged E17.5, P1.5 and P7.5 and for one replicate of E15.5. Data acquisition
and normalization were performed as described previously.
6 The microarray data
ﬁles were deposited in the GEO/NCBI public database identiﬁed as GSE25965
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE25965).
RT-qPCR. To validate the differentially expressed genes from microarray
experiments, the initial sample set was evaluated using RT-qPCR, which is referred
to here as technical validation. cDNA was synthesized from 2mg of aRNA using
SuperScript III (Invitrogen) and random hexamer primers. For an independent
sampleset,whichisreferredtohereasbiologicalvalidation,cDNAwassynthesized
from 2mg of DNase-treated total RNA using IMPROM II (Promega, Madison, WI,
USA)and oligo-dT(24)primers,accordingto themanufacturer’sprotocol. RT-qPCR
was performed in the ABI Prism 7900 sequence detection system (Applied
Biosystems) using SYBR Green PCR Master Mix (Applied Biosystems) in a 20ml
total volume. All reactions were performed in duplicate, and no-template reactions
wereusedasanegativecontrol.Theampliﬁcationefﬁciencyofeachprimerpairwas
calculated using standard curve dilutions
35 (Table 4). ACTB and GAPDH were
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Cell Death and Diseaseselected as the most stable control genes from four endogenous genes tested
(GAPDH, ACTB, HPRT1 and BCR) using the geNorm algorithm.
36
TMA construction and immunohistochemistry assays. Formalin-
ﬁxed, parafﬁn-embedded (FFPE) WT and kidney specimens from 145 and 20
patients, respectively, were obtained from the Pathology Department of the A.C.
Camargo Hospital. For tissue microarray (TMA) construction, hematoxylin and eosin
sectionswereanalyzed,andarepresentativeareaofthetumorblastemalcomponent
and the kidney cortex region was marked on the slide. Selected areas from each
sample were arrayed once with a 1.0-mm diameter core that was spaced 0.2mm
apart using a Tissue Microarrayer (Beecher Instruments, Silver Spring, MD, USA).
Additional slides from 19 FFPE postmortem human fetuses at 13 to 24 weeks
(i.e. 13, 17, 18, 19, 20, 21, 22 and 24 weeks) of gestation were obtained from the
Universityof Sa ˜o Paulo MedicalSchoolin accordancewith theauthorizationof their
ethics committee.
Slides were deparafﬁnized, rehydrated and then subjected to antigen retrieval.
The antigen retrieval method details and primary antibody clones are described in
Table 5. Sections were incubated in 3% aqueous hydrogen peroxide for 15min to
quench endogenous peroxidase activity and treated with serum-free protein block
(Dako, Copenhagen, Denmark) for 20min at room temperature to suppress
nonspeciﬁc binding. Immunohistochemical reactions were performed using a
polymer technique (Dako). The slides were incubated with the biotinylated
secondaryantibodyfromthe LSABþ peroxidasekit (Dako), followedby incubation
with streptavidin–horseradish peroxidase (HRP) (Dako) and were then counter-
stained with hematoxylin.
Western blot analysis was performed to check the speciﬁcity of antibodies used
in IHC assay. HEK293 (CRL-1573) and SK-NEP-1 (HTB-48) cell lines (American
Type Culture Collection, ATCC, Manassas, VA, USA) were maintained in a
humidiﬁed incubator at 371C in the presence of 5% CO2. The HEK293 cell line was
cultured in DMEM medium (Gibco, Carlsbad, CA, USA) supplemented with 10%
FBS and 1% L-glutamine, and SK-NEP-1 cells were maintained in McCoy’s 5A
medium (Gibco) supplemented with 15% FBS and 1% L-glutamine. Total protein
were extract from subconﬂuent culture cells with cold RIPA buffer (50mM Tris-HCl
(pH8.0),150mMNaCl,1%NonidetP-40,0.5%sodiumdeoxicolate,0.1%SDSand
1  complete, mini protease inhibitor cocktail (Roche, Mannheim, Germany) and
1  PhosSTOP phosphatase inhibitor cocktail (Roche)) and western blot assays
were performed as described previously.
37 Proteins were detected using rabbit
polyclonal anti-GRK7 (1:500), anti-WNT5B (1:100), anti-TIMP3 (1mg/ml),
anti-FZD2 (1mg/ml), anti-IGF2 (1:1000), anti-TESK1 (1:500) and mouse
monoclonal anti-CRABP2 (1:250) and anti-HDGF (1:500) antibodies. Signals
were detected using ECL HRP-conjugated immunoglobulin G whole antibodies
(1:2000, GE Healthcare, Little Chalfont, UK).
Protein localization was determined for the nucleus, membrane and cytoplasm.
Immunohistochemical expression was quantitatively analyzed using the Automated
Cellular Imaging System III (ACIS) (Dako), which detects hue, saturation and
luminosity levels and converts these signals into a numerical density measurement
that ranges from 0 to 256. Each cell compartment (nucleus, membrane and
cytoplasm) evaluated using the ACIS equipment requires an independent slide
scanning. Therefore, the number of high-quality images of each protein able to cell
recognition and intensity measurement could vary.
For each of the eight proteins analyzed, the pathologist established a limit
intensity value by visual evaluation, and this was considered the cutoff value
(Table 5). Samples with intensity values lower than the cutoff and/or with o10% of
cells labeled were considered to be negatively stained. Accordingly, samples with
intensity values higher than the cutoff intensity were considered to be positively
stained.ForDKs,onlyglomerularcellswereusedforthisanalysisbecauseofahigh
level of nonspeciﬁc labeling of tubule cells.
Mathematical and statistical analysis. Student’s t-test was used to
identify differentially expressed genes between WT and DK in the cDNA microarray
experiments. The differentially expressed genes were annotated in the Gene
Ontology Database biological process categories and organized in a hierarchical
manner through automated EASE gene function analysis.
38 To characterize gene
expression modulation during the four stages of nephrogenesis, the average signal
Table 4 Characteristics of primers used for qRT-PCR.
Genes Forward primer Reverse primer Ampliﬁed fragment (pb) Ampliﬁcation efﬁciency (%)
ACTB CAGGATGCAGAAGGAG CTGCTGGAAGGTGGAC 130 100
GAPDH CTTTGTCAAGCTCATTTCC CTTACTCCTTGGAGGCC 92 100
SHPK CCTTGGGTGATTTACAG GAATCCTGAAGGCATGG 110 100
CRABP2 GGTGAAATGGGAGAGTG CGTAGACCCTGGTGCAC 152 100
FRZB GTGGAAGGATCGACTCG GAGTTCCTGCCAGACTTC 124 120
HDGF GCTACCAAGGAAGATGCTG GACAGCAGCAGGAACAGG 100 100
HIPK1 GACCAGTGCAGCACAAC GCTGGGTTGCTGCTTC 87 106
IGF2 CTGGAGACGTACTGTGC GCTTCCAGGTGTCATATTG 114 100
ITPR3 CAACTCCACCATGAAGCTG GTTCTGGACATCCACAAAGC 61 106
PAX2 CACTCTGCCTGGTTACC GTGGCTGTACGGGTTG 115 100
PIK3CA GTGATTAGTAAAGGAGCCC GAGATTGGCATGCTGTCG 105 96
TESK1 CCTTCACCGAAATTACCCA GGAAGCGTGGCAGAGG 130 100
TIMP3 CTGAACTATCGGTATCACC CTCGTTCTTGGAAGTCAC 84 100
WNT5B CTCATGAACCTGCACAAC CTACATGAGCCGGACAC 95 100
Table 5 Antibodies, retrieval characteristics and evaluated localization of each protein with the correspondent limit intensity used for deﬁning positive and negative
samples
Protein Antibody Title Dilution Antigen retrieval Localization Cutoff
CRABP2 Mouse polyclonal anti-CRABP2 MAB5488, Chemicon (Temecula, CA, USA) 1:2000 Citrate, pH 6.0 cytoplasm 81
nucleus 96
FZD2 Rabbit polyclonal anti-FZD2 AB26396, Abcam (Temecula, CA, USA) 1:2000 EDTA-TRIS, pH 9.0 membrane 73
HDGF Monoclonal anti-HDGF AB58644, Abcam 1:100 Citrate, pH 6.0 cytoplasm 80
nucleus 110
GRK7 Rabbit polyclonal anti-GRK7 AP7731b, Abgent (San Diego, CA, USA) 1:100 Citrate, pH 6.0 cytoplasm 85
membrane 91
TIMP3 Mouse monoclonal anti-TIMP3 AB49670, Abcam 1:100 EDTA-TRIS, pH 8.0 cytoplasm 70
membrane 69
WNT5B Rabbit polyclonal anti-WNT5B LS-A8730, Lifespan (Seattle, WA, USA) 1:400 Citrate, pH 6.0 cytoplasm 103
membrane 88
TESK1 Rabbit polyclonal anti-TESK1 AP7820b, Abgent 1:200 Citrate, pH 6.0 cytoplasm 68
IGF2 Rabbit polyclonal anti-IGF2 LS-C7512, Lifespan 1:2000 Citrate, pH 6.0 cytoplasm 75
WTand kidney development
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graphs to create a curve to report the expression tendency. Pearson’s correlation
and complete linkage were used for nonsupervised hierarchical clustering, and
reliability was assessed by bootstrapping using TMEV version 4.6.
For RT-qPCR experiments, relative fold changes were calculated considering
primer efﬁciency, and genes were considered to be differentially expressed when
theyreachedthepreviouslydescribedcriteriaofaP-valueo0.05bythet-testanda
fold change Z3 to avoid artifactual results in the relative gene expression data, as
recommended previously.
39
Membrane, cytoplasm and nucleus density measurements from immunohis-
tochemistry assays were plotted in a graph, and Student’s t-test was applied to ﬁnd
signiﬁcant differences in labeling between WT blastemal cells and DK glomerular
cells (Pr0.05).
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